Tower Research Capital (TRC)’s Vivos Therapeutics VVOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57K | Buy |
+497
| New | +$1.57K | ﹤0.01% | 4788 |
|
|
2025
Q1 | – | Sell |
-161
| Closed | -$691 | – | 5845 |
|
|
2024
Q4 | $691 | Sell |
161
-1,502
| -90% | -$6.45K | ﹤0.01% | 5200 |
|
|
2024
Q3 | $4.34K | Sell |
1,663
-620
| -27% | -$1.62K | ﹤0.01% | 4581 |
|
|
2024
Q2 | $5.07K | Buy |
2,283
+554
| +32% | +$1.23K | ﹤0.01% | 4721 |
|
|
2024
Q1 | $8.35K | Buy |
1,729
+11
| +0.6% | +$53 | ﹤0.01% | 4031 |
|
|
2023
Q4 | $21.4K | Buy |
+1,718
| New | +$21.4K | ﹤0.01% | 3604 |
|
|
2023
Q3 | – | Sell |
-983
| Closed | -$12.5K | – | 6249 |
|
|
2023
Q2 | $12.5K | Sell |
983
-345
| -26% | -$4.4K | ﹤0.01% | 3836 |
|
|
2023
Q1 | $11K | Buy |
1,328
+651
| +96% | +$5.39K | ﹤0.01% | 4276 |
|
|
2022
Q4 | $7K | Buy |
677
+146
| +27% | +$1.51K | ﹤0.01% | 4632 |
|
|
2022
Q3 | $9K | Buy |
531
+391
| +279% | +$6.63K | ﹤0.01% | 4703 |
|
|
2022
Q2 | $5K | Sell |
140
-12
| -8% | -$429 | ﹤0.01% | 5109 |
|
|
2022
Q1 | $10K | Sell |
152
-66
| -30% | -$4.34K | ﹤0.01% | 4361 |
|
|
2021
Q4 | $12K | Sell |
218
-1,287
| -86% | -$70.8K | ﹤0.01% | 4332 |
|
|
2021
Q3 | $152K | Buy |
+1,505
| New | +$152K | ﹤0.01% | 2062 |
|
|
2021
Q2 | – | Sell |
-15
| Closed | -$2K | – | 5879 |
|
|
2021
Q1 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 5055 |
|